Optimization of the dipeptide motifs in the PSMA ligands linker structure: synthesis and in vitro evaluation
An improved series of ligands targeting prostatic specific membrane antigen has been reported. Varying compounds and their biological parameters were due to changes in the linker structure. Highly selective compounds with nanomolar IC 50 values were obtained. As an example, a conjugate with Sulfo-Cy...
Saved in:
Published in | Medicinal chemistry research Vol. 32; no. 1; pp. 32 - 37 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.01.2023
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | An improved series of ligands targeting prostatic specific membrane antigen has been reported. Varying compounds and their biological parameters were due to changes in the linker structure. Highly selective compounds with nanomolar IC
50
values were obtained. As an example, a conjugate with Sulfo-Cy5 and MMAE was obtained and pre-studied.
Graphical Abstract |
---|---|
AbstractList | An improved series of ligands targeting prostatic specific membrane antigen has been reported. Varying compounds and their biological parameters were due to changes in the linker structure. Highly selective compounds with nanomolar IC
50
values were obtained. As an example, a conjugate with Sulfo-Cy5 and MMAE was obtained and pre-studied.
Graphical Abstract An improved series of ligands targeting prostatic specific membrane antigen has been reported. Varying compounds and their biological parameters were due to changes in the linker structure. Highly selective compounds with nanomolar IC50 values were obtained. As an example, a conjugate with Sulfo-Cy5 and MMAE was obtained and pre-studied. |
Author | Machulkin, Aleksei E. Uspenskaya, Anastasiia A. Skvortsov, Dmitry A. Zyk, Nikolay Y. Beloglazkina, Elena K. Evteev, Sergei A. Majouga, Alexander G. Nimenko, Ekaterina A. Ivanenkov, Yan A. Garanina, Anastasiia S. Shafikov, Radik R. Dashkova, Natalia S. |
Author_xml | – sequence: 1 givenname: Anastasiia A. orcidid: 0000-0002-2451-8336 surname: Uspenskaya fullname: Uspenskaya, Anastasiia A. email: uspenskaya.n@gmail.com organization: Chemistry Department, Lomonosov Moscow State University – sequence: 2 givenname: Ekaterina A. surname: Nimenko fullname: Nimenko, Ekaterina A. organization: Chemistry Department, Lomonosov Moscow State University – sequence: 3 givenname: Radik R. surname: Shafikov fullname: Shafikov, Radik R. organization: Chemistry Department, Lomonosov Moscow State University, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry Russian Academy of Sciences – sequence: 4 givenname: Nikolay Y. surname: Zyk fullname: Zyk, Nikolay Y. organization: Chemistry Department, Lomonosov Moscow State University – sequence: 5 givenname: Sergei A. surname: Evteev fullname: Evteev, Sergei A. organization: The Federal State Unitary Enterprise Dukhov Automatics Research Institute – sequence: 6 givenname: Natalia S. surname: Dashkova fullname: Dashkova, Natalia S. organization: Chemistry Department, Lomonosov Moscow State University – sequence: 7 givenname: Yan A. surname: Ivanenkov fullname: Ivanenkov, Yan A. organization: Chemistry Department, Lomonosov Moscow State University, The Federal State Unitary Enterprise Dukhov Automatics Research Institute, National University of Science and Technology «MISiS», Institute of Biochemistry and Genetics Ufa Science Centre Russian Academy of Sciences (IBG RAS) – sequence: 8 givenname: Alexander G. surname: Majouga fullname: Majouga, Alexander G. organization: Chemistry Department, Lomonosov Moscow State University, National University of Science and Technology «MISiS», Dmitry Mendeleev University of Chemical Technology of Russia – sequence: 9 givenname: Dmitry A. surname: Skvortsov fullname: Skvortsov, Dmitry A. organization: Chemistry Department, Lomonosov Moscow State University – sequence: 10 givenname: Anastasiia S. surname: Garanina fullname: Garanina, Anastasiia S. organization: National University of Science and Technology «MISiS» – sequence: 11 givenname: Elena K. surname: Beloglazkina fullname: Beloglazkina, Elena K. organization: Chemistry Department, Lomonosov Moscow State University – sequence: 12 givenname: Aleksei E. surname: Machulkin fullname: Machulkin, Aleksei E. organization: Chemistry Department, Lomonosov Moscow State University |
BookMark | eNp9kEtLxDAUhYMoOD7-gKuA6-rNozZ1Nwy-QBlBXYe0TTRjJx2TdAb99cZWEFzM6h4u57uPc4B2Xec0QicEzghAcR4AgPMMKM2AAdBss4MmJM95JgiF3aQhaZpTto8OQlgAsAJ4PkHtfBXt0n6paDuHO4Pjm8aNXenUbjRedtGagK0b-o9PD1Pc2lflmpCqe9ceh-j7OvZeX-Lw6ZIr2ICT4YdZ2-g7rNeq7Yf5R2jPqDbo4996iF6ur55nt9n9_OZuNr3PakbKmImCCKZVXrKyUiSvK2EaXWtem6riuRGcqoJUxlAhcsbTv2XylZUgqmrKC8PZITod565899HrEOWi671LKyUtLgglIGiZXHR01b4LwWsjV94ulf-UBORPqnJMVaZU5ZCq3CRI_INqG4fnole23Y6yEQ1pj3vV_u-qLdQ3pR2Qcw |
CitedBy_id | crossref_primary_10_71267_mencom_7583 crossref_primary_10_1016_j_bmcl_2024_130025 crossref_primary_10_1021_acsptsci_4c00070 crossref_primary_10_1016_j_jconrel_2024_09_040 crossref_primary_10_1134_S1070428024080013 crossref_primary_10_31857_S0514749224020058 crossref_primary_10_3390_ijms241411327 |
Cites_doi | 10.1021/acs.jmedchem.1c01157 10.2174/0929867328666210804092200 10.1016/j.bmc.2018.11.022 10.1021/acs.jmedchem.0c01935 10.7150/thno.18719 10.1158/1078-0432.CCR-18-0803 10.1016/j.bmcl.2019.06.035 10.14309/ctg.0000000000000041 10.1093/annonc/mdx370 10.2967/jnumed.116.178533 10.1039/c0md00273a 10.1016/j.bioorg.2019.103154 10.3390/molecules25245784 10.1038/s41598-021-86551-1 10.3322/caac.21660 10.1158/1078-0432.CCR-14-0891 10.2967/jnumed.115.158550 10.1056/nejmoa2107322 10.1021/cr100048w |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. |
DBID | AAYXX CITATION 8FD FR3 M7Z P64 |
DOI | 10.1007/s00044-022-03002-w |
DatabaseName | CrossRef Technology Research Database Engineering Research Database Biochemistry Abstracts 1 Biotechnology and BioEngineering Abstracts |
DatabaseTitle | CrossRef Biochemistry Abstracts 1 Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | Biochemistry Abstracts 1 |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1554-8120 |
EndPage | 37 |
ExternalDocumentID | 10_1007_s00044_022_03002_w |
GroupedDBID | --- -56 -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 203 29M 29~ 2J2 2JN 2JY 2KG 2LR 2VQ 2~H 30V 4.4 406 408 409 40D 40E 5GY 5VS 67N 67Z 6NX 78A 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACSNA ACZOJ ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFFNX AFGCZ AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BAPOH BDATZ BGNMA BSONS CAG COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBLON EBS EIOEI EJD EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HLICF HMJXF HQYDN HRMNR HVGLF HZ~ IHE IJ- IKXTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M4Y MA- N2Q NB0 NPVJJ NQJWS NU0 O9- O93 O9I O9J OAM P2P PF0 PT4 QOR QOS R89 R9I RIG ROL RPX RSV S16 S1Z S27 S3A S3B SAP SBL SDH SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZN T13 TSG TSK TSV TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WK8 YLTOR Z45 Z7U Z7V Z87 ZMTXR ZOVNA ~A9 ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION 8FD ABRTQ FR3 M7Z P64 |
ID | FETCH-LOGICAL-c319t-87183ea5939ba15cb8fdece4cfbb45f842a71bff28853403099ba9b81abd96f43 |
IEDL.DBID | U2A |
ISSN | 1054-2523 |
IngestDate | Fri Jul 25 11:03:26 EDT 2025 Tue Jul 01 01:53:35 EDT 2025 Thu Apr 24 23:04:36 EDT 2025 Fri Feb 21 02:46:34 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Monomethyl auristatin E Drug delivery Sulfo-Cy5 label Prostate cancer Prostate-specific membrane antigen |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c319t-87183ea5939ba15cb8fdece4cfbb45f842a71bff28853403099ba9b81abd96f43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
ORCID | 0000-0002-2451-8336 |
PQID | 2761210829 |
PQPubID | 2043723 |
PageCount | 6 |
ParticipantIDs | proquest_journals_2761210829 crossref_primary_10_1007_s00044_022_03002_w crossref_citationtrail_10_1007_s00044_022_03002_w springer_journals_10_1007_s00044_022_03002_w |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20230100 2023-01-00 20230101 |
PublicationDateYYYYMMDD | 2023-01-01 |
PublicationDate_xml | – month: 1 year: 2023 text: 20230100 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: Heidelberg |
PublicationTitle | Medicinal chemistry research |
PublicationTitleAbbrev | Med Chem Res |
PublicationYear | 2023 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | El-Faham, Albericio (CR15) 2011; 111 Schmidt (CR17) 2017 Sung, Ferlay, Siegel, Laversanne, Soerjomataram, Jemal (CR1) 2021; 71 Machulkin, Skvortsov, Ivanenkov, Ber, Kavalchuk, Aladinskaya (CR18) 2019; 29 Kularatne, Thomas, Myers, Gagare, Kanduluru, Crian (CR9) 2019; 25 Barinka, Novakova, Hin, Bím, Ferrari, Duvall (CR4) 2019; 27 Boinapally, Ahn, Cheng, Brummet, Nam, Gabrielson (CR10) 2021; 11 Jiao, Li, Yang, Han, Wu, Shi (CR2) 2019; 10 Sengupta, Krishnan, Pandit, Dudhe, Sharma, Chelvam (CR11) 2019; 91 Sartor, Bono, Chi, Fizazi, Herrmann, Rahbar (CR3) 2021; 385 Chi, Protheroe, Rodriguez Antolin, Facchini, Suttmann, Matsubara (CR5) 2017; 28 Petrov, Machulkin, Uspenskaya, Zyk, Nimenko, Garanina (CR19) 2020; 25 Neuman, Eifler, Castanares, Chowdhury, Chen, Mease (CR8) 2015; 21 Ahmadzadehfar, Azgomi, Hauser, Wei, Yordanova, Gaertner (CR7) 2017; 58 Wang, Shirke, Walker, Sun, Ramamurthy, Wang (CR20) 2021; 13 Weineisen, Schottelius, Simecek, Baum, Yildiz, Beykan (CR12) 2015; 56 Machulkin, Shafikov, Uspenskaya, Petrov, Ber, Skvortsov (CR13) 2021; 64 Uspenskaya, Nimenko, Machulkin, Beloglazkina, Majouga (CR14) 2021; 28 Choy, Ling, Geruntho, Beyer, Latoche, Langton-Webster (CR6) 2017; 7 Machulkin, Uspenskaya, Zyk, Nimenko, Ber, Petrov (CR21) 2021; 64 East, Carter, Kennedy, Schulte, Toews, Lynch (CR16) 2011; 2 A El-Faham (3002_CR15) 2011; 111 K Chi (3002_CR5) 2017; 28 AE Machulkin (3002_CR18) 2019; 29 CJ Choy (3002_CR6) 2017; 7 SA Kularatne (3002_CR9) 2019; 25 JE East (3002_CR16) 2011; 2 H Ahmadzadehfar (3002_CR7) 2017; 58 S Sengupta (3002_CR11) 2019; 91 S Boinapally (3002_CR10) 2021; 11 O Sartor (3002_CR3) 2021; 385 C Barinka (3002_CR4) 2019; 27 AE Machulkin (3002_CR21) 2021; 64 D Jiao (3002_CR2) 2019; 10 X Wang (3002_CR20) 2021; 13 BP Neuman (3002_CR8) 2015; 21 AE Machulkin (3002_CR13) 2021; 64 H Sung (3002_CR1) 2021; 71 AA Uspenskaya (3002_CR14) 2021; 28 A Schmidt (3002_CR17) 2017 SA Petrov (3002_CR19) 2020; 25 M Weineisen (3002_CR12) 2015; 56 |
References_xml | – volume: 64 start-page: 17123 year: 2021 end-page: 45 ident: CR21 article-title: Synthesis, characterization, and preclinical evaluation of a small-molecule prostate-specific membrane antigen-targeted monomethyl auristatin E conjugate publication-title: J Med Chem doi: 10.1021/acs.jmedchem.1c01157 – volume: 28 start-page: 1 year: 2021 end-page: 31 ident: CR14 article-title: The importance of linkers in the structure of PSMA ligands publication-title: Curr Med Chem doi: 10.2174/0929867328666210804092200 – volume: 27 start-page: 255 year: 2019 end-page: 64 ident: CR4 article-title: Structural and computational basis for potent inhibition of glutamate carboxypeptidase II by carbamate-based inhibitors publication-title: Bioorg Med Chem doi: 10.1016/j.bmc.2018.11.022 – volume: 64 start-page: 4532 year: 2021 end-page: 52 ident: CR13 article-title: Synthesis and biological evaluation of PSMA ligands with aromatic residues and fluorescent conjugates based on them publication-title: J Med Chem doi: 10.1021/acs.jmedchem.0c01935 – year: 2017 ident: CR17 publication-title: Structural modifications of PSMA ligands to optimize their pharmacokinetics – volume: 7 start-page: 1928 year: 2017 end-page: 39 ident: CR6 article-title: 177Lu-labeled phosphoramidate-based PSMA inhibitors: the effect of an albumin binder on biodistribution and therapeutic efficacy in prostate tumor-bearing mice publication-title: Theranostics doi: 10.7150/thno.18719 – volume: 25 start-page: 177 year: 2019 end-page: 87 ident: CR9 article-title: Evaluation of novel prostate-specific membrane antigen-targeted near-infrared imaging agent for fluorescence-guided surgery of prostate cancer publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-18-0803 – volume: 29 start-page: 2229 year: 2019 end-page: 35 ident: CR18 article-title: Synthesis and biological evaluation of PSMA-targeting paclitaxel conjugates publication-title: Bioorg Med Chem Lett doi: 10.1016/j.bmcl.2019.06.035 – volume: 10 start-page: 1 year: 2019 end-page: 7 ident: CR2 article-title: Expression of prostate-specific membrane antigen in tumor-associated vasculature predicts poor prognosis in hepatocellular carcinoma publication-title: Clin Transl Gastroenterol doi: 10.14309/ctg.0000000000000041 – volume: 28 start-page: v269. year: 2017 ident: CR5 article-title: Benefits of abiraterone acetate plus prednisone (AA+P) when added to androgen deprivation therapy (ADT) in LATITUDE on patient (Pt) reported outcomes (PRO) publication-title: Ann Oncol doi: 10.1093/annonc/mdx370 – volume: 58 start-page: 438 year: 2017 end-page: 44 ident: CR7 article-title: 68Ga-PSMA-11 PET as a gatekeeper for the treatment of metastatic prostate cancer with 223Ra: proof of concept publication-title: J Nucl Med doi: 10.2967/jnumed.116.178533 – volume: 2 start-page: 325 year: 2011 end-page: 30 ident: CR16 article-title: Development of a phosphatase-resistant, l-tyrosine derived LPA1/LPA3 dual antagonist publication-title: Medchemcomm doi: 10.1039/c0md00273a – volume: 91 start-page: 103154. year: 2019 ident: CR11 article-title: Tyrosine-based asymmetric urea ligand for prostate carcinoma: tuning biological efficacy through in silico studies publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2019.103154 – volume: 25 start-page: 5784 year: 2020 ident: CR19 article-title: Polypeptide-based molecular platform and its docetaxel/sulfo-Cy5-containing conjugate for targeted delivery to prostate specific membrane antigen publication-title: Molecules doi: 10.3390/molecules25245784 – volume: 11 start-page: 1 year: 2021 end-page: 10 ident: CR10 article-title: A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile publication-title: Sci Rep doi: 10.1038/s41598-021-86551-1 – volume: 71 start-page: 209 year: 2021 end-page: 49 ident: CR1 article-title: Global Cancer Statistics 2020 Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries publication-title: CA Cancer J Clin doi: 10.3322/caac.21660 – volume: 21 start-page: 771 year: 2015 end-page: 80 ident: CR8 article-title: Real-time, near-infrared fluorescence imaging with an optimized dye/light source/camera combination for surgical guidance of prostate cancer publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-14-0891 – volume: 56 start-page: 1169 year: 2015 end-page: 76 ident: CR12 article-title: Ga- and Lu-labeled PSMA I & T: optimization of a PSMA targeted theranostic concept and first proof of concept human studies publication-title: J Nucl Med doi: 10.2967/jnumed.115.158550 – volume: 385 start-page: 1091 year: 2021 end-page: 103 ident: CR3 article-title: Lutetium-177–PSMA-617 for metastatic castration-resistant prostate cancer publication-title: N. Engl J Med doi: 10.1056/nejmoa2107322 – volume: 13 start-page: 1 year: 2021 end-page: 21 ident: CR20 article-title: Small molecule-based prodrug targeting prostate specific membrane antigen for the treatment of prostate cancer publication-title: Cancers (Basel) – volume: 111 start-page: 6557 year: 2011 end-page: 602 ident: CR15 article-title: Peptide coupling reagents, more than a letter soup publication-title: Chem Rev doi: 10.1021/cr100048w – volume: 25 start-page: 177 year: 2019 ident: 3002_CR9 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-18-0803 – volume: 25 start-page: 5784 year: 2020 ident: 3002_CR19 publication-title: Molecules doi: 10.3390/molecules25245784 – volume: 10 start-page: 1 year: 2019 ident: 3002_CR2 publication-title: Clin Transl Gastroenterol doi: 10.14309/ctg.0000000000000041 – volume: 21 start-page: 771 year: 2015 ident: 3002_CR8 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-14-0891 – volume: 71 start-page: 209 year: 2021 ident: 3002_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21660 – volume: 58 start-page: 438 year: 2017 ident: 3002_CR7 publication-title: J Nucl Med doi: 10.2967/jnumed.116.178533 – volume: 56 start-page: 1169 year: 2015 ident: 3002_CR12 publication-title: J Nucl Med doi: 10.2967/jnumed.115.158550 – volume: 11 start-page: 1 year: 2021 ident: 3002_CR10 publication-title: Sci Rep doi: 10.1038/s41598-021-86551-1 – volume-title: Structural modifications of PSMA ligands to optimize their pharmacokinetics year: 2017 ident: 3002_CR17 – volume: 111 start-page: 6557 year: 2011 ident: 3002_CR15 publication-title: Chem Rev doi: 10.1021/cr100048w – volume: 27 start-page: 255 year: 2019 ident: 3002_CR4 publication-title: Bioorg Med Chem doi: 10.1016/j.bmc.2018.11.022 – volume: 28 start-page: 1 year: 2021 ident: 3002_CR14 publication-title: Curr Med Chem doi: 10.2174/0929867328666210804092200 – volume: 91 start-page: 103154. year: 2019 ident: 3002_CR11 publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2019.103154 – volume: 2 start-page: 325 year: 2011 ident: 3002_CR16 publication-title: Medchemcomm doi: 10.1039/c0md00273a – volume: 13 start-page: 1 year: 2021 ident: 3002_CR20 publication-title: Cancers (Basel) – volume: 28 start-page: v269. year: 2017 ident: 3002_CR5 publication-title: Ann Oncol doi: 10.1093/annonc/mdx370 – volume: 29 start-page: 2229 year: 2019 ident: 3002_CR18 publication-title: Bioorg Med Chem Lett doi: 10.1016/j.bmcl.2019.06.035 – volume: 7 start-page: 1928 year: 2017 ident: 3002_CR6 publication-title: Theranostics doi: 10.7150/thno.18719 – volume: 64 start-page: 4532 year: 2021 ident: 3002_CR13 publication-title: J Med Chem doi: 10.1021/acs.jmedchem.0c01935 – volume: 64 start-page: 17123 year: 2021 ident: 3002_CR21 publication-title: J Med Chem doi: 10.1021/acs.jmedchem.1c01157 – volume: 385 start-page: 1091 year: 2021 ident: 3002_CR3 publication-title: N. Engl J Med doi: 10.1056/nejmoa2107322 |
SSID | ssj0037045 |
Score | 2.3249176 |
Snippet | An improved series of ligands targeting prostatic specific membrane antigen has been reported. Varying compounds and their biological parameters were due to... |
SourceID | proquest crossref springer |
SourceType | Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 32 |
SubjectTerms | Antigens Biochemistry Biomedical and Life Sciences Biomedicine Bioorganic Chemistry Brief Report Inorganic Chemistry Ligands Medicinal Chemistry Optimization Pharmacology/Toxicology |
Title | Optimization of the dipeptide motifs in the PSMA ligands linker structure: synthesis and in vitro evaluation |
URI | https://link.springer.com/article/10.1007/s00044-022-03002-w https://www.proquest.com/docview/2761210829 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NT8IwFG8ULl6MnxFF0oPhIktY17HN2zAg0YgkQoKnpd1aswQHYSjhv_e121g0auJpyfbaQ1_f1957v4fQFTOZFA53jDYnzKDUcw1uhsSgMgJ1KYWKQlS1xbAzmND7qT3Nm8LSotq9SElqTb1tdtPJR0NVn8PFBDle76KqDbG7KuSaEL_Qv5bT1qOJwXGgBoE4K2-V-XmPr-ao9DG_pUW1tekfoP3cTcR-xtdDtCOSI9QcZTjTmxYel21TaQs38ahEoN4co9kTKIK3vMMSzyUGLw9H8UJVsEQCq_o7meI40e9Hz48-nsWvqucXq4MRS5yhyr4vxQ1ONwlQpXGKgUCt-YhXyzkuUcJP0KTfG98OjHysghGCvK1A_4EYC2Z7lseZaYfclZEIBQ0l59SWLiXMMbmUxAVTTlUKBug87pqMR15HUusUVZJ5Is4Q9tpAKghxmZA0ci3GGEQcVkd2ojAEWa8hszjdIMwxx9Xoi1mwRUvWHAmAI4HmSLCuoevtmkWGuPEndb1gWpBLXxoQR-OiucSroVbByPLz77ud_4_8Au2p6fPZH5k6qgBvxCX4KCveQFW_3-0O1fPu5aHX0Ff0EzfP4kw |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fT9swED4x9sBe0DaY1gHjHgYvNFLjuI0ziYdqA5XxqxKtxFtmJzaK1KWoKVT9f_aH7uwkjZi2SXvgNTlbkb-78zl39xngk_Sl0aEKvY5i0uM8Ep7yE-Zxk5K7NNqeQmy1xVVvMObfbru3a_Cz7oVx1e51StJ56lWzm0s-erb6nBST7HhRlVKe6-WCDmrF8dlXQvWAsdOT0ZeBV90l4CWkZHMyetJdLbtRECnpdxMlTKoTzROjFO8awZkMfWUME7R_cZt3ILlICV-qNOoZHtC8L-AlBR_C2s6Y9Wt_H4QddxUyBSrcY3Suq1pz_vzNT7e_Jqb9LQ3rdrfT17BZhaXYL_XoDazp_C0cDkte62UbR02bVtHGQxw2jNfLLZhck-P5UXV04tQgRZWYZve2YibVaOv9TIFZ7p4Pby77OMnubI8xWiD0DEsW24eZ_ozFMiepIiuQBOyYx2w-m2LDSr4N42dZ-newnk9z_R4w6pCoZkxIbXgqAiklnXCCnumlSUK-pQV-vbpxUnGc26s2JvGKndkhEhMisUMkXrTgaDXmvmT4-Kf0bg1aXFl7EbPQ8bAJFrWgXQPZvP77bB_-T3wfNgajy4v44uzqfAdeMYq3yr9Bu7BOOOk9io_m6qNTT4Tvz20PvwBsHB1c |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dT9swED8xkKa9ID42rYOxexi8rBGN4zYJEg8VrILxVWlU4i2zE3uKVNKqKVT9r_gTd3aSRiCGxAOvydmK_Ls7n3N3PwN8F67Qype-05JMOJyHgSPdmDlcJ-QutTKnEFNtcdk5GfBfN-2bJXioemFstXuVkix6GgxLUzbdHyd6f9H4ZhORjqlEJyUlm56VZZVnaj6jQ1t-eHpMCO8y1vt5fXTilPcKODEp3JQcAOmxEu3QC6Vw27EMdKJixWMtJW_rgDPhu1JrFtBexk0OguRCGbhCJmFHc4_mfQcr3HQfkwUNWLfy_Z7fstciU9DCHUZnvLJN5_lvfrwV1vHtk5Ss3el6a7BahqjYLXRqHZZUtgF7_YLjet7E67plK2_iHvZr9uv5JgyvyAndlt2dONJIESYm6dhUzyQKTe2fzjHN7PP-74suDtO_pt8YDShqggWj7d1EHWA-z0gqT3MkATPmPp1ORlgzlH-EwZss_SdYzkaZ-gwYtkhUMRYIpXkSeEIIOu14Hd1J4pj8TAPcanWjuOQ7N9duDKMFU7NFJCJEIotINGvAj8WYccH28aL0dgVaVFp-HjHfcrIFLGxAswKyfv3_2b68TvwbvO8f96Lz08uzLfjAKPQqfgxtwzLBpL5SqDSVO1Y7Ef68tTn8A-S2IY8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optimization+of+the+dipeptide+motifs+in+the+PSMA+ligands+linker+structure%3A+synthesis+and+in+vitro+evaluation&rft.jtitle=Medicinal+chemistry+research&rft.au=Uspenskaya%2C+Anastasiia+A&rft.au=Nimenko%2C+Ekaterina+A&rft.au=Shafikov+Radik+R&rft.au=Zyk%2C+Nikolay+Y&rft.date=2023-01-01&rft.pub=Springer+Nature+B.V&rft.issn=1054-2523&rft.eissn=1554-8120&rft.volume=32&rft.issue=1&rft.spage=32&rft.epage=37&rft_id=info:doi/10.1007%2Fs00044-022-03002-w&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1054-2523&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1054-2523&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1054-2523&client=summon |